Clinical Trials in Pittsburgh

Showing 19081-19100 of 21,047 trials

PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children

NCT00153114

Assess the safety and efficacy of polyethyleneglycol3350 laxative as compared to placebo therapy in pediatric patients with a history of constipation.

Constipation

Braintree Laboratories100 participantsStarted Jan 2003

Boston, Massachusetts, United States • Morristown, New Jersey, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 4< 1 mile

Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery

NCT00659945

Hypothesis: Aprepitant plus ondansetron is more effective than ondansetron plus placebo for prevention of postoperative emesis in patients at moderate-to-high risk for PONV for up to 48 hours after surgery. Specific Aim: To determine the incidence of PONV during the first 48 hours after surgery; in patients who have received aprepitant plus ondansetron versus ondansetron plus placebo for up to 48 hours after surgery.

Postoperative Nausea and Vomiting

University of Pittsburgh150 participantsStarted Jun 2008

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 4< 1 mile

Antidepressant Medication Plus Donepezil for Treating Late-life Depression

NCT00177671

This study will determine the effectiveness of combining escitalopram, venlafaxine, or duloxetine with donepezil, a medication used in Alzheimer's disease, in improving memory, concentration, attention, and problem solving abilities, and reducing the risk of depressive relapse in older individuals with depression.

DepressionDementia

University of Pittsburgh220 participantsStarted Dec 2003

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

NCT00006102

Phase II trial to study the effectiveness of rebeccamycin analogue in treating children who have solid tumors or non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Brain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more

National Cancer Institute (NCI)200 participantsStarted Jul 2000

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +223 more locations

PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children

Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery

Antidepressant Medication Plus Donepezil for Treating Late-life Depression

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Find Trials by Condition in Pittsburgh

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas

Ultrasound Assessment of Gastric Emptying

Prescription Opioid Addiction Treatment Study (POATS)

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

Topotecan in Treating Children With Refractory Leukemia

Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy

Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating Pain

Embryonic Dopamine Cell Implants for Parkinson's Disease

Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma